NCT02305940View on ClinicalTrials.gov

Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 12, 2017

Study Completion Date

July 12, 2017

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Doxycycline

An oral dose of 100 mg of Doxycycline once daily, for a total duration of 52 weeks.

DRUG

Placebo

An oral dose of one capsule of placebo once daily, for a total duration of 52 weeks

Trial Locations (3)

L9 7AL

Aintree University Hospital NHS Foundation Trust, Liverpool

SW17 0RE

St Georges University Hospitals NHS Foundation Trust, London

SW36NP

Royal Brompton and Harefield Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT02305940 - Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients | Biotech Hunter | Biotech Hunter